Allicin Alleviates Dextran Sodium Sulfate- (DSS-) Induced Ulcerative Colitis in BALB/c Mice

Oxidative Medicine and Cellular Longevity

Volumn 2015, Issue , 2015, Pages

  Pandurangan, Ashok Kumar ^a,b   Ismail, Salmiah ^a   Saadatdoust, Zeinab ^a   Esa, Norhaizan Mohd ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^b UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHROPOMETRY; ANTIOXIDANTS; DEXTRAN; MAMMALS; OXYGEN; PEPTIDES; POTABLE WATER; SODIUM;

ANTI-INFLAMMATORY EFFECTS; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; NUCLEAR ACCUMULATION; NUCLEAR TRANSLOCATIONS; PRO-INFLAMMATORY CYTOKINES; SUPEROXIDE DISMUTASES; TUMOR NECROSIS FACTORS;

SODIUM SULFATE;

ALLICIN; CATALASE; CD68 ANTIGEN; DEXTRAN SULFATE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 6; MALONALDEHYDE; MESSENGER RNA; MYELOPEROXIDASE; STAT3 PROTEIN; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; ANTIOXIDANT; CD68 ANTIGEN, HUMAN; CYTOKINE; DIFFERENTIATION ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LEUKOCYTE ANTIGEN; PEROXIDASE; STAT3 PROTEIN, MOUSE; SULFINIC ACID DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; MOUSE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; ULCERATIVE COLITIS; WEIGHT REDUCTION; ANIMAL; BAGG ALBINO MOUSE; CHEMICALLY INDUCED; COLITIS, ULCERATIVE; COLON; CONFOCAL MICROSCOPY; DISEASE MODEL; DRUG EFFECTS; ENZYMOLOGY; GENETICS; METABOLISM; REAL TIME POLYMERASE CHAIN REACTION;

MURINAE; MUS;

ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; ANTIOXIDANTS; COLITIS, ULCERATIVE; COLON; CYTOKINES; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; MALONDIALDEHYDE; MICE; MICE, INBRED BALB C; MICROSCOPY, CONFOCAL; NF-KAPPA B; PEROXIDASE; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; STAT3 TRANSCRIPTION FACTOR; SULFINIC ACIDS;

EID: 84929629758     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2015/605208     Document Type: Article

References (51)

1. X. Niu, T. Fan, W. Li, H. Huang, Y. Zhang, and W. Xing, "Protective effect of sanguinarine against acetic acid-induced ulcerative colitis in mice," Toxicology and Applied Pharmacology, vol. 267, no. 3, pp. 256-265, 2013.
2. F. S. Velayos and W. J. Sandborn, "Positioning biologic therapy for Crohn's disease and ulcerative colitis," Current Gastroenterology Reports, vol. 9, no. 6, pp. 521-527, 2007.
3. M. Krimsky, S. Yedgar, L. Aptekar et al., "Amelioration of TNBS-induced colon inflammation in rats by phospholipase A2 inhibitor," American Journal of Physiology - Gastrointestinal and Liver Physiology, vol. 285, no. 3, pp. G586-G592, 2003.
4. F. Sanchez-Muñoz, A. Dominguez-Lopez, and J. K. Yamamoto-Furusho, "Role of cytokines in inflammatory bowel disease," World Journal of Gastroenterology, vol. 14, no. 27, pp. 4280-4288, 2008.
5. E. K. Shin, H.-S. Kwon, Y. H. Kim, H.-K. Shin, and J.-K. Kim, "Chrysin, a natural flavone, improves murine inflammatory bowel diseases," Biochemical and Biophysical Research Communications, vol. 381, no. 4, pp. 502-507, 2009.
6. I. Andújar, J. L. Ríos, R. M. Giner, J. Miguel Cerdá, and M. D. C. Recio, "Beneficial effect of shikonin on experimental colitis induced by dextran sulfate sodium in Balb/C mice," Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 271606, 15 pages, 2012.
7. A. K. Pandurangan and N. M. Esa, "Signal transducer and activator of transcription 3 - a promising target in colitis-associated cancer," Asian Pacific Journal of Cancer Prevention, vol. 15, no. 2, pp. 551-560, 2014.
8. J. Borlinghaus, F. Albrecht, M. Gruhlke, I. Nwachukwu, and A. Slusarenko, "Allicin: chemistry and biological properties," Molecules, vol. 19, no. 8, pp. 12591-12618, 2014.
9. X. Gu, H. Wu, and P. Fu, "Allicin attenuates inflammation and suppresses HLA-B27 protein expression in ankylosing spondylitis mice," BioMed Research International, vol. 2013, Article ID 171573, 6 pages, 2013.
10. W. Jiang, Y. Huang, J.-P. Wang, X.-Y. Yu, and L.-Y. Zhang, "The synergistic anticancer effect of artesunate combined with allicin in osteosarcoma cell line in vitro and in vivo," Asian Pacific Journal of Cancer Prevention, vol. 14, no. 8, pp. 4615-4619, 2013.
11. L. Xu, J. Yu, D. Zhai et al., "Role of JNK activation and mitochondrial Bax translocation in allicin-induced apoptosis in human ovarian cancer SKOV3 cells," Evidence-Based Complementary and Alternative Medicine, vol. 2014, Article ID 378684, 6 pages, 2014.
12. J. Y. Chan, H. Tsui, I. Y. Chung, R. Y. Chan, Y. Kwan, and S. Chan, "Allicin protects rat cardiomyoblasts (H9c2 cells) from hydrogen peroxide-induced oxidative injury through inhibiting the generation of intracellular reactive oxygen species," International Journal of Food Sciences and Nutrition, vol. 65, no. 7, pp. 868-873, 2014.
13. L. Zhang, E. Wang, F. Chen, H. Yan, and Y. Yuan, "Potential protective effects of oral administration of allicin on acrylamide-induced toxicity in male mice," Food & Function, vol. 4, no. 8, pp.1229-1236,2013.
14. W. Bat-Chen, T. Golan, I. Peri, Z. Ludmer, and B. Schwartz, "Allicin purified from fresh garlic cloves induces apoptosis in colon cancer cells via Nrf2," Nutrition and Cancer, vol. 62, no. 7, pp. 947-957, 2010.
15. H. C. Rath, H. H. Herfarth, J. S. Ikeda et al., "Normal luminal bacteria, especially bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human β2 microglobulin transgenic rats," Journal of Clinical Investigation, vol. 98, no. 4, pp. 945-953, 1996.
16. M. van der Sluis, B. A. E. de Koning, A. C. J. M. de Bruijn et al., "Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection," Gastroenterology, vol. 131, no. 1, pp. 117-129, 2006.
17. K. Suzuki, H. Ota, S. Sasagawa, T. Sakatani, and T. Fujikura, "Assay method for myeloperoxidase in human polymorphonuclear leukocytes," Analytical Biochemistry, vol. 132, no. 2, pp. 345-352, 1983.
18. H. Ohkawa, N. Ohishi, and K. Yagi, "Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction," Analytical Biochemistry, vol. 95, no. 2, pp. 351-358, 1979.
19. P. Kakkar, B. Das, and P. N. Viswanathan, "A modified spectrophotometric assay of superoxide dismutase," Indian Journal of Biochemistry and Biophysics, vol. 21, no. 2, pp. 130-132, 1984.
20. A. K. Sinha, "Colorimetric assay of catalase," Analytical Biochemistry, vol. 47, no. 2, pp. 389-394, 1972.
21. I. Carlberg and B. Mannervik, "Glutathione reductase," in Methods in Enzymology, vol. 7, pp. 484-490, Academic Press, New York, NY, USA, 1985.
22. J. T. Rotruck, A. L. Pope, H. E. Ganther, A. B. Swanson, D. G. Hafeman, and W. G. Hoekstra, "Selenium: biochemical role as a component of glatathione peroxidase," Science, vol. 179, no. 4073, pp. 588-590, 1973.
23. A. K. Pandurangan, S. K. Ananda Sadagopan, P. Dharmalingam, and S. Ganapasam, "Luteolin inhibits Matrix metalloproteinase 9 and 2 in Azoxymethane-induced colon carcinogenesis," Human & Experimental Toxicology, vol. 33, no. 11, pp. 1176-1185, 2014.
24. A. K. Pandurangan, Z. Saadatdoust, N. Mohd. Esa, H. Hamzah, and A. Ismail, "Dietary cocoa protects against colitis-associated cancer by activating the Nrf2/Keap1 pathway," BioFactors, vol. 41, no. 1, pp. 1-14, 2015.
25. A. F. Bento, R. Marcon, R. C. Dutra et al., "Beta-caryophyllene inhibits dextran sulfate sodium induced colitis in mice through CB2 receptor activation and PPARgamma pathway," The American Journal of Pathology, vol. 178, no. 3, pp. 1153-1166, 2011.
26. S. Choudhary, A. Keshavarzian, S. Yong et al., "Novel antioxidants Zolimid and AEOL11201 ameliorate colitis in rats," Digestive Diseases and Sciences, vol. 46, no. 10, pp. 2222-2230, 2001.
27. I. Andújar, M. C. Recio, R. M. Gineretal., "Inhibition of ulcerative colitis in mice after oral administration of a polyphenol-enriched cocoa extract is mediated by the inhibition of STAT1 and STAT3 phosphorylation in colon cells," Journal of Agricultural and Food Chemistry, vol. 59, no. 12, pp. 6474-6483, 2011.
28. L. Xu, Z.-L. Yang, P. Li, and Y.-Q. Zhou, "Modulating effect of Hesperidin on experimental murine colitis induced by dextran sulfate sodium," Phytomedicine, vol. 16, no. 10, pp. 989-995, 2009.
29. B. B. Aggarwal, A. B. Kunnumakkara, K. B. Harikumar et al., "Signal transducer and activator of transcription-3, inflammation, and cancer: how intimate is the relationship?" Annals of the New York Academy of Sciences, vol. 1171, pp. 59-76, 2009.
30. J.-P. Spano, G. Milano, C. Rixe, and R. Fagard, "JAK/STAT signalling pathway in colorectal cancer: a new biological target with therapeutic implications," European Journal of Cancer, vol. 42, no. 16, pp. 2668-2670, 2006.
31. J. K. Kundu and Y.-J. Surh, "Inflammation: gearing the journey to cancer," Mutation Research: Reviews in Mutation Research, vol. 659, no. 1-2, pp. 15-30, 2008.
32. L. Lenoir, A. Rossary, J. Joubert-Zakeyhetal., "Lemonverbena infusion consumption attenuates oxidative stress in dextran sulfate sodium-induced colitis in the rat," Digestive Diseases and Sciences, vol. 56, no. 12, pp. 3534-3545, 2011.
33. P. Ashokkumar and G. Sudhandiran, "Protective role of luteolin on the status of lipid peroxidation and antioxidant defense against azoxymethane-induced experimental colon carcinogenesis," Biomedicine and Pharmacotherapy, vol. 62, no. 9, pp. 590-597, 2008.
34. L. Kruidenier, I. Kuiper, W. van Duijn et al., "Imbalanced secondary mucosal antioxidant response in inflammatory bowel disease," Journal of Pathology, vol. 201, no. 1, pp. 17-27, 2003.
35. R. Ito, M. Kita, M. Shin-Ya et al., "Involvement of IL-17A in the pathogenesis of DSS-induced colitis in mice," Biochemical and Biophysical Research Communications, vol. 377, no. 1, pp. 12-16, 2008.
36. A. Araki, H. Nara, M. Rahman et al., "Role of interleukin-21 isoform in dextran sulfate sodium (DSS)-induced colitis," Cytokine, vol. 62, no. 2, pp. 262-271, 2013.
37. A. Lang, M. Lahav, E. Sakhnini et al., "Allicin inhibits spontaneous and TNF-α induced secretion of proinflammatory cytokines and chemokines from intestinal epithelial cells," Clinical Nutrition, vol. 23, no. 5, pp. 1199-1208, 2004.
38. J. H. Shin, J. H. Ryu, M. J. Kang, C. R. Hwang, J. Han, and D. Kang, "Short-term heating reduces the anti-inflammatory effects of fresh raw garlic extracts on the LPS-induced production of NO and pro-inflammatory cytokines by downregulating allicin activity in RAW 264.7 macrophages," Food and Chemical Toxicology, vol. 58, pp. 545-551, 2013.
39. A. S. Baldwin Jr., "The NF-κB and IκB proteins: new discoveries and insights," Annual Review of Immunology, vol. 14, pp. 649-681, 1996.
40. M. J. May and S. Ghosh, "Signal transduction through NF-κB," Immunology Today, vol. 19, no. 2, pp. 80-88, 1998.
41. I. Atreya, R. Atreya, and M. F. Neurath, "NF-κB in inflammatory bowel disease," Journal of Internal Medicine, vol. 263, no. 6, pp. 591-596, 2008.
42. K. Wang, C. Zhang, S. Zhang et al., "3-(3-Pyridylmethylidene)-2-indolinone reduces the severity of colonic injury in a murine model of experimental colitis," Oxidative Medicine and Cellular Longevity, vol. 2015, Article ID 959253, 11 pages, 2015.
43. A.-K. Spiik, A. Ridderstad, L.-G. Axelsson, T. Midtvedt, L. Björk, and S. Pettersson, "Abrogated lymphocyte infiltration and lowered CD14 in dextran sulfate induced colitis in mice treated with p65 antisense oligonucleotides," International Journal of Colorectal Disease, vol. 17, no. 4, pp. 223-232, 2002.
44. M. S. Islam, T. Murata, M. Fujisawa et al., "Anti-inflammatory effects of phytosteryl ferulates in colitis induced by dextran sulphate sodium in mice," British Journal of Pharmacology, vol. 154, no. 4, pp. 812-824, 2008.
45. R. Bruck, H. Aeed, E. Brazovsky, T. Noor, and R. Hershkoviz, "Allicin, the active component of garlic, prevents immune-mediated, concanavalin A-induced hepatic injury in mice," Liver International, vol. 25, no. 3, pp. 613-621, 2005.
46. P. Lovato, C. Brender, J. Agnholt et al., "Constitutive STAT3 activation in intestinal T cells from patients with Crohn's disease," The Journal of Biological Chemistry, vol. 278, no. 19, pp. 16777-16781, 2003.
47. J. Mudter, B. Weigmann, B. Bartsch et al., "Activation pattern of signal transducers and activators of transcription (STAT) factors in inflammatory bowel diseases," American Journal of Gastroenterology, vol. 100, no. 1, pp. 64-72, 2005.
48. M. J. Waldner and M. F. Neurath, "Master regulator of intestinal disease: IL-6 in chronic inflammation and cancer development," Seminars in Immunology, vol. 26, no. 1, pp. 75-79, 2014.
49. K. G. Kumar, R. Dhamotharan, N. M. Kulkarni, S. Honnegowda, and S. Murugesan, "Embelin ameliorates dextran sodium sulfate-induced colitis in mice," International Immunopharmacology, vol. 11, no. 6, pp. 724-731, 2011.
50. E. Degagné, A. Pandurangan, P. Bandhuvula et al., "Sphingosine-1-phosphate lyase downregulation promotes colon carcinogenesis through STAT3-activated microRNAs," The Journal of Clinical Investigation, vol. 124, no. 12, pp. 5368-5384, 2014.
51. Y. Li, C. Yu, W.-M. Zhu et al., "Triptolide ameliorates IL-10-deficient mice colitis by mechanisms involving suppression of IL-6/STAT3 signaling pathway and down-regulation of IL-17," Molecular Immunology, vol. 47, no. 15, pp. 2467-2474, 2010.